PDL BioPharma (NASDAQ: PDLI) announced that Paul R. Edick has been appointed to the company's board of directors. Mr. Edick ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE